Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO
reports
Organogenesis Holdings (ORGO) Stock Price & Analysis
364 Followers
ORGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.23 - $9.27
Previous Close$2.8
Volume622.69K
Average Volume (3M)672.61K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$107.25M
Total Debt (Recent Filing)$130.71M
Price to Earnings (P/E)6.1
Beta1.18
Next EarningsMar 14, 2023
EPS Estimate$0.06
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)0.46
Shares Outstanding130,915,099
R-Squared0.14
Standard Deviation0.22
10 Day Avg. Volume615,943
30 Day Avg. Volume672,608
Price to Book (P/B)1.63
Price to Sales (P/S)1.03
Price to Cash Flow (P/CF)9.70
P/FCF Ratio-54.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusHold
Alpha-0.03
Number of Analyst Covering1
Organogenesis Holdings News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ORGO FAQ
What was Organogenesis Holdings’s price range in the past 12 months?
Organogenesis Holdings lowest stock price was $2.23 and its highest was $9.27 in the past 12 months.
What is Organogenesis Holdings’s market cap?
Currently, no data Available
When is Organogenesis Holdings’s upcoming earnings report date?
Organogenesis Holdings’s upcoming earnings report date is Mar 14, 2023 which is in 38 days.
How were Organogenesis Holdings’s earnings last quarter?
Organogenesis Holdings released its earnings results on Nov 09, 2022. The company reported $0.037 earnings per share for the quarter, missing the consensus estimate of $0.059 by -$0.022.
Is Organogenesis Holdings overvalued?
According to Wall Street analysts Organogenesis Holdings’s price is currently Overvalued.
Does Organogenesis Holdings pay dividends?
Organogenesis Holdings does not currently pay dividends.
What is Organogenesis Holdings’s EPS estimate?
Organogenesis Holdings’s EPS estimate is $0.06.
How many shares outstanding does Organogenesis Holdings have?
Organogenesis Holdings has 130,915,100 shares outstanding.
What happened to Organogenesis Holdings’s price movement after its last earnings report?
Organogenesis Holdings reported an EPS of $0.037 in its last earnings report, missing expectations of $0.059. Following the earnings report the stock price went down -14.887%.
Which hedge fund is a major shareholder of Organogenesis Holdings?
Among the largest hedge funds holding Organogenesis Holdings’s share is Royce & Associates LLC. It holds Organogenesis Holdings’s shares valued at 54K.
---
Organogenesis Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
―
―
Blogger Sentiment
Bullish
ORGO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 4.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $15.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.33%
12-Months-Change
Fundamentals
Return on Equity
27.27%
Trailing 12-Months
Asset Growth
23.45%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Organogenesis Holdings Inc
Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
---
---